HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isosteviol Sodium Protects Against Permanent Cerebral Ischemia Injury in Mice via Inhibition of NF-κB-Mediated Inflammatory and Apoptotic Responses.

AbstractBACKGROUND:
Isosteviol sodium (STVNa) has been reported to have neuroprotective effects against ischemia/reperfusion (I/R) injury in rats. Furthermore, recanalization treatments, including thrombolytic therapy, have several limitations. Excessive inflammation and apoptosis contribute to the pathogenesis of ischemic brain damage. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is critical to these processes and is associated with cerebral ischemia. Therefore, we studied the potential therapeutic effects and mechanisms of STVNa on permanent cerebral ischemia in mice.
METHODS:
Permanent middle cerebral artery occlusion (pMCAO) was established via the suture method, followed by intravenous STVNa (7.5, 15, 30, 45, and 60 mg/kg). Neurobehavioral deficits, infarct volume, and histology were examined 24 hours after cerebral ischemia. In addition, the messenger RNA (mRNA) expression of NF-κB-related genes was detected using real-time quantitative polymerase chain reaction (qPCR).
RESULTS:
STVNa (30 mg/kg) had significant neuroprotective effects 24 hours after pMCAO, including the reduction of the infarct volume and the improvement of the neurological severity score. Immunohistochemistry demonstrated that STVNa significantly increased the number of restored neurons and decreased the number of astrocytes. qPCR also demonstrated that the mRNA expression of inhibitor of nuclear factor kappa-B kinase-α, inhibitor of nuclear factor kappa-B kinase-β, NF-κB, inhibitor of NF-κB-α, tumor necrosis factor-α, interleukin-1 beta, Bcl2-associated X protein, and caspase-3 were significantly downregulated, whereas B-cell CLL/lymphoma 2 mRNA was upregulated with STVNa treatment compared with vehicle.
CONCLUSIONS:
These findings demonstrate a neuroprotective role of STVNa during cerebral ischemia, which may result from interactions with the NF-κB signaling pathway and the associated inflammatory and apoptotic responses.
AuthorsHao Zhang, Xiaoou Sun, Yanxiang Xie, Jie Zan, Wen Tan
JournalJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (J Stroke Cerebrovasc Dis) Vol. 26 Issue 11 Pg. 2603-2614 (Nov 2017) ISSN: 1532-8511 [Electronic] United States
PMID28784277 (Publication Type: Journal Article)
CopyrightCopyright © 2017. Published by Elsevier Inc.
Chemical References
  • Cytokines
  • Diterpenes, Kaurane
  • Glial Fibrillary Acidic Protein
  • NF-kappa B
  • Neuroprotective Agents
  • isosteviol
  • Caspase 3
Topics
  • Animals
  • Apoptosis (drug effects)
  • Brain Injuries (etiology, prevention & control)
  • Brain Ischemia (complications)
  • Caspase 3 (metabolism)
  • Cerebrovascular Circulation (drug effects)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Diterpenes, Kaurane (therapeutic use)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Glial Fibrillary Acidic Protein (metabolism)
  • Inflammation (drug therapy, etiology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B (genetics, metabolism)
  • Neurologic Examination
  • Neuroprotective Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: